AzTrials
AzTrials

ElectroencephalographyNCT03622242

Validity of Pain Threshold Index in Children

A study testing Pain threshold index and Wavelet index in people with Electroencephalography and Anesthesia, General, run by Seoul National University Hospital at 1 site in South Korea.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Comparison of total infused dose of remifentanil between pain threshold index monitoring group and control group Read more about this study

Who is it for?
Ages 3 to 12 years
Conditions the study is for
Electroencephalography, Anesthesia, General
What is being tested?
Pain threshold index and Wavelet index
Could I receive a placebo?
No, everyone receives an active treatment
How many people
180 participants
Where
1 siteSouth Korea
Study dates
13 Aug 2018to 31 Jul 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 12 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Children between 3 and 12 years old undergoing orthopedic surgery at extremities under general anesthesia

Who cannot join

  • History of adverse drug reactions to opioids
  • Underlying neurological disease or taking medication for neurologic purpose
  • Patients who were transferred to intensive care unit after the surgery

Trial locations and contacts

1 site in 1 country.

Sang-Hwan Ji, M.D., M.S. contact

+82-10-9251-5019

taepoongshin@gmail.com

Young-Eun Jang, M.D., M.S. contact

+82-10-9487-2233

na0ag2@hotmail.com

South Korea1 site, 1 recruiting
  • Seoul National University Hospital

    Seoul, 03080

    Hee-Soo Kim, MD, Ph.D, +82-2-2072-3661, dami0605@snu.ac.kr

    Sang-Hwan Ji, MD, MS, +82-2-2072-3661, taepoongshin@gmail.com

    Recruiting

Other trials in South Korea

About this study

Official title: Validity of Pain Threshold Index Based on Electroencephalogram for Pediatric Patients Under General Anesthesia

Comparison of total infused dose of remifentanil between pain threshold index monitoring group and control group

Read the detailed description

Investigators plan to enroll pediatric patients aged between 3 and 12 years old undergoing surgery under general anesthesia with continuous infusion of 2% propofol and remifentanil.

After dividing them into two groups, investigators monitor pain threshold index and wavelet index in test group and adjust remifentanil infusion to maintain both indices in desirable range, while monitoring only wavelet index and adjust remifentanil infusion to maintain wavelet index and conventional vital signs in desirable range in control group.

Investigators compare consumption of remifentanil, time to extubation after surgery, and post-anesthesia care unit length of stay between both groups.

Being tested
Pain threshold index, Wavelet index

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pain threshold indexDevice

    In pain threshold index monitor, monitor patients' pain threshold index based on electroencephalography and adjust infusion rate of remifentanil and propofol according to pain threshold index

  • Wavelet indexDevice

    In wavelet index monitor, monitor patients' wavelet index based on electroencephalography as an indicator of depth of anesthesia and adjust infusion rate of propofol according to wavelet index

Study groups in NCT03622242
Study groupRoleWhat they receive
Pain threshold index groupExperimentalAdjust infusion rate of remifentanil and propofol according to pain threshold index and wavelet index in 'pain threshold index group'.
Receives: Device: Pain threshold index; Device: Wavelet index
Control groupActive comparatorAs conventional management, adjust infusion rate of remifentanil and propofol according to wavelet index and conventional vital signs
Receives: Device: Wavelet index

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Remifentanil consumption

    Total amount of infused remifentanil divided by patient's weight and total anesthesia time

    Measured: At the end of anesthesia, total anesthesia time less than 1 day

Secondary outcomes (2)
  1. Extubation time

    Elapsed time from end of surgery to extubation

    Measured: At the end of anesthesia, less than 1 hour

  2. Post-anesthesia care unit length of stay

    Length of stay at post-anesthesia care unit

    Measured: At discharge from post-anesthesia care unit, less than 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Aug 2018
  2. Study start13 Aug 2018
  3. Primary completion30 Jun 2019 (estimated)
  4. Study completion31 Jul 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
180 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03622242
Sponsor's protocol ID
D-1804-059-936
Status last verified
Aug 2018
First submitted
8 Jul 2018
Last updated
16 Aug 2018
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Edry R, Recea V, Dikust Y, Sessler DI. Preliminary Intraoperative Validation of the Nociception Level Index: A Noninvasive Nociception Monitor. Anesthesiology. 2016 Jul;125(1):193-203. doi: 10.1097/ALN.0000000000001130.

    PubMed 27171828
  • Funcke S, Sauerlaender S, Pinnschmidt HO, Saugel B, Bremer K, Reuter DA, Nitzschke R. Validation of Innovative Techniques for Monitoring Nociception during General Anesthesia: A Clinical Study Using Tetanic and Intracutaneous Electrical Stimulation. Anesthesiology. 2017 Aug;127(2):272-283. doi: 10.1097/ALN.0000000000001670.

    PubMed 28489614
  • Constant I, Sabourdin N. Monitoring depth of anesthesia: from consciousness to nociception. A window on subcortical brain activity. Paediatr Anaesth. 2015 Jan;25(1):73-82. doi: 10.1111/pan.12586. Epub 2014 Nov 20.

    PubMed 25410376
  • Huiku M, Uutela K, van Gils M, Korhonen I, Kymalainen M, Merilainen P, Paloheimo M, Rantanen M, Takala P, Viertio-Oja H, Yli-Hankala A. Assessment of surgical stress during general anaesthesia. Br J Anaesth. 2007 Apr;98(4):447-55. doi: 10.1093/bja/aem004. Epub 2007 Feb 28.

    PubMed 17329347
  • Chen X, Thee C, Gruenewald M, Ilies C, Hocker J, Hanss R, Steinfath M, Bein B. Correlation of surgical pleth index with stress hormones during propofol-remifentanil anaesthesia. ScientificWorldJournal. 2012;2012:879158. doi: 10.1100/2012/879158. Epub 2012 Sep 2.

    PubMed 22973178
  • Bonhomme V, Uutela K, Hans G, Maquoi I, Born JD, Brichant JF, Lamy M, Hans P. Comparison of the surgical Pleth Index with haemodynamic variables to assess nociception-anti-nociception balance during general anaesthesia. Br J Anaesth. 2011 Jan;106(1):101-11. doi: 10.1093/bja/aeq291. Epub 2010 Nov 4.

    PubMed 21051493
  • Colombo R, Raimondi F, Corona A, Rivetti I, Pagani F, Porta VD, Guzzetti S. Comparison of the Surgical Pleth Index with autonomic nervous system modulation on cardiac activity during general anaesthesia: A randomised cross-over study. Eur J Anaesthesiol. 2014 Feb;31(2):76-84. doi: 10.1097/01.EJA.0000436116.06728.b3.

    PubMed 24284309
  • Bergmann I, Gohner A, Crozier TA, Hesjedal B, Wiese CH, Popov AF, Bauer M, Hinz JM. Surgical pleth index-guided remifentanil administration reduces remifentanil and propofol consumption and shortens recovery times in outpatient anaesthesia. Br J Anaesth. 2013 Apr;110(4):622-8. doi: 10.1093/bja/aes426. Epub 2012 Dec 5.

    PubMed 23220856
  • Won YJ, Lim BG, Lee SH, Park S, Kim H, Lee IO, Kong MH. Comparison of relative oxycodone consumption in surgical pleth index-guided analgesia versus conventional analgesia during sevoflurane anesthesia: A randomized controlled trial. Medicine (Baltimore). 2016 Aug;95(35):e4743. doi: 10.1097/MD.0000000000004743.

    PubMed 27583920
  • Ilies C, Ludwigs J, Gruenewald M, Thee C, Hanf J, Hanss R, Steinfath M, Bein B. The effect of posture and anaesthetic technique on the surgical pleth index. Anaesthesia. 2012 May;67(5):508-513. doi: 10.1111/j.1365-2044.2011.07051.x. Epub 2012 Feb 11.

    PubMed 22324319
  • Won YJ, Lim BG, Yeo GE, Lee MK, Lee DK, Kim H, Lee IO, Kong MH. The effect of nicardipine on the surgical pleth index during thyroidectomy under general anesthesia: A prospective double-blind randomized controlled trial. Medicine (Baltimore). 2017 Feb;96(6):e6154. doi: 10.1097/MD.0000000000006154.

    PubMed 28178175
  • Park JH, Lim BG, Kim H, Lee IO, Kong MH, Kim NS. Comparison of Surgical Pleth Index-guided Analgesia with Conventional Analgesia Practices in Children: A Randomized Controlled Trial. Anesthesiology. 2015 Jun;122(6):1280-7. doi: 10.1097/ALN.0000000000000650.

    PubMed 25815454
  • An JX, Wang Y, Cope DK, Williams JP. Quantitative Evaluation of Pain with Pain Index Extracted from Electroencephalogram. Chin Med J (Engl). 2017 Aug 20;130(16):1926-1931. doi: 10.4103/0366-6999.211878.

    PubMed 28776544

Questions about this trial

What is this clinical trial studying?

A study testing Pain threshold index and Wavelet index in people with Electroencephalography and Anesthesia, General, run by Seoul National University Hospital at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 16 Aug 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Sang-Hwan Ji, M.D., M.S. (+82-10-9251-5019, taepoongshin@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Remifentanil consumption (time frame: At the end of anesthesia, total anesthesia time less than 1 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03622242, which also lists 13 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Aug 2018; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in